A Comparative Analysis on the Efficacy and Safety of Intaxel® and Taxol® in Advanced Metastatic Breast Cancer

Background: Among the presently available cytotoxic drugs, paclitaxel, in combination with doxorubicin and carboplatin, come under the highly active therapy for metastatic breast cancer. Between the two brands of paclitaxel (Intaxel, which is marketed by Fresenius Kabi and Taxol, the original paclit...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lang, Istvan, Rubovszky, Gabor, Horvath, Zsolt, Ganofszky, Erna, Szabo, Eszter, Dank, Magdolna, Boer, Katalin, Hitre, Erika
Natura: Artigo
Lingua:Inglês
Pubblicazione: JCDR Research and Publications (P) Limited 2013
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3708212/
https://ncbi.nlm.nih.gov/pubmed/23905117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2013/4742.3027
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi